Jon Pont, MD
Obstetrics & Gynecology · Modesto, CANPI 1912957259
Payments from drug & device makers
Across 57 payments — averaging $118.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Boston Scientific$731
- Applied Medical Resources Corporation$305
- AbbVie$137
- Hologic Sales And Service, LLC$56
- Coopersurgical, Inc.$52
- plus $240 from 10 others
What the payments were for
- Travel & lodging$4,34164%
- Food & beverage$2,24033%
- Education$1352%
- Gifts$361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $5,230 |
| Boston Scientific | 6 | $731 |
| Applied Medical Resources Corporation | 3 | $305 |
| AbbVie | 8 | $137 |
| Hologic Sales And Service, LLC | 3 | $56 |
| Coopersurgical, Inc. | 3 | $52 |
| AMAG Pharmaceuticals, Inc. | 2 | $43 |
| Johnson & Johnson | 1 | $33 |
| Avanos Medical | 2 | $33 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Lupin Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Aspira Women's Health Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,898
- GENERAL FEMALE SUI$643
- GELPOINT VPATH$213
How this compares
$6,751 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 70 | $1,909 |
| Oxybutynin Chloride ErOxybutynin Chloride | 32 | $975 |
| Medroxyprogesterone Acetate | 18 | $206 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Modesto
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
- Vanessa JacobySan Francisco$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.